Results 121 to 130 of about 113,904,810 (178)

Antiemetic-associated QT prolongation: a clinical review and risk-stratified prescribing framework for long QT syndrome. [PDF]

Eur Heart J Cardiovasc Pharmacother
Moustafa AT, Dabash O, Panigrahi PK, Khan HR.   +3 more
europepmc   +1 more source

Efficacy of steroid-omitting antiemetic therapy in patients with advanced pancreatic cancer receiving nano-liposomal irinotecan plus fluorouracil and leucovorin. [PDF]

Support Care Cancer
Tokito Y, Ishigaki K, Nara K, Endo G, Nishio H, Fukuda K, Suzuki T, Sato Y, Takahara N, Boku N, Fujishiro M.   +10 more
europepmc   +1 more source

A pharmacoeconomic evaluation of aprepitant injection versus aprepitant capsules for the prevention of CINV caused by moderately and highly emetogenic chemotherapy. [PDF]

Front Pharmacol
Chen Z, Cai M, Dong Y, Jin L, Li M, Shen L, Jiang X.   +6 more
europepmc   +1 more source

Anti-Inflammatory Evaluation of Pyrazino[2,1-<i>b</i>]quinazoline-3,6-dione Derivatives Inspired by Fiscalin B. [PDF]

Pharmaceuticals (Basel)
Martins MS, Pinto MMM, Almeida IF, Cruz MT, Sousa E.   +4 more
europepmc   +1 more source

Comparative effectiveness and safety of ondansetron-based dual versus triple antiemetic regimens for chemotherapy-induced nausea and vomiting. [PDF]

Medicine (Baltimore)
Yu X, Yuan Y, Qiao G, Zheng W, Liu Z, Mao J, Yu L, Deng Z, Lin H, Zhang J.   +9 more
europepmc   +1 more source

Regulation of Aldosterone Secretion by Substance P and the Neurokinin Type 1 Receptor in Aldosterone-Producing Adenomas. [PDF]

J Am Heart Assoc
Lopez AG, Duparc C, Renouf S, D'Agostino M, De Sousa K, Amar L, Defortescu G, Manceau G, Sabourin JC, Fernandes-Rosa FL, Zennaro MC, Meatchi T, Nicolas G, Louiset E, Lefebvre H.   +14 more
europepmc   +1 more source

Managing trastuzumab deruxtecan-related adverse events in patients with metastatic breast cancer: insights from a worldwide survey of the Hermione EDUcational project. [PDF]

Support Care Cancer
Cazzaniga ME, Aapro M, Bianchi MA, Charalambous A, Cortesi L, Costa L, Fashing P, Garcia ABR, Gilles F, Hennessy B, Iihara H, Lapuente M, Ma F, Matesanz IR, McCann KE, Park YH, Rugo HS, Sakai H, Strasser F, Walbaum B, Wang S.   +20 more
europepmc   +1 more source

Diagnostic and Therapeutic Potential of Substance P/NK1 Receptor in Primary Dysmenorrhea: A Pilot Study. [PDF]

Health Sci Rep
Mehboob R, Shahid I, Alzahrani AR, Yousof SM, Adnan H, Ekram SN, Alwazzan A, Nasief H, Khadawardi KA.   +8 more
europepmc   +1 more source

Targeting Peptidergic Systems for Melanoma Treatment. [PDF]

Cancers (Basel)
Sánchez ML, Mehboob R, Coveñas R.
europepmc   +1 more source

Neuropeptide and cytokines expression in long COVID-19 related neuropsychological sequelae: insights into NK1R-mediated neuroinflammation and <i>in silico</i> therapeutic targeting. [PDF]

Front Cell Neurosci
Abdullah M, Naz A, Reznikov LR, Qureshi JA, Hasnain A, Obaid A, Ali A.   +6 more
europepmc   +1 more source